Gilead's three-drug HIV regimen wins European panel approval

(Reuters) – Gilead Sciences Inc said on Friday its three-drug regimen to treat HIV infection was recommended for approval by a panel of the European Medicines Agency, paving the way for the biotech company to capture more sales in the multibillion-dollar market.


Source: Reuters Medical News

Teens who get more sleep may curb screen time

(Reuters Health) – When teens get extra sleep on school nights, they might cut back mostly on sedentary activities like screen time without making major changes to their exercise habits, a small experiment suggests.


Source: Reuters Medical News

Air pollution linked to fertility treatment failure

(Reuters Health) – Women exposed to high levels of air pollution may have less success getting pregnant with fertility treatments or staying pregnant, compared to women breathing cleaner air, a South Korean study suggests.


Source: Reuters Medical News

Friends and family may help counter diabetes stress

(Reuters Health) – People with diabetes may have healthier blood sugar levels when they get lots of encouragement from family and friends to help them overcome the stress of managing their disease, a U.S. study suggests.


Source: Reuters Medical News

AbbVie's beat fueled by demand for Humira, Hep C drugs

(Reuters) – AbbVie Inc reported a better-than-expected quarterly profit on Thursday, on higher sales of its rheumatoid arthritis treatment Humira and its Hepatitis C drugs, leading the company to raise its full-year earnings forecast.


Source: Reuters Medical News